Why is Biogen Pharma falling/rising?

As of 19-Nov, Biogen Pharmachem Industries Ltd is experiencing a decline in its stock price, currently at Rs 0.78, which reflects a decrease of Rs 0.01 or 1.27%. The stock has underperformed significantly, with a 1-week return of -3.70% and a 1-month return of -6.02%. Additionally, it is trading lower than all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. The stock is also close to its 52-week low, just 3.85% above Rs 0.75. Furthermore, there has been a notable drop in investor participation, with delivery volume falling by 13.13% compared to the 5-day average, indicating reduced interest in trading the stock.
In the broader market context, Biogen Pharma's performance contrasts sharply with the Sensex, which has gained 0.85% over the past week and 1.47% over the past month. Year-to-date, Biogen's stock has plummeted by 33.90%, while the Sensex has risen by 9.02%. This stark difference highlights the stock's struggles relative to the overall market. Unfortunately, there is no information available regarding positive or negative factors that could further explain the stock's recent movement.